TQB3217

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3217, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors [Phase 1]

See pricing